Latest news
Sionna Halts SION-719 After Phase 2a Miss, Eyes SION-451 Combination Path - MarketBeatMarketBeat · Tue, 11 Aug 2026 04:12:34 GMTSionna Therapeutics (NASDAQ:SION) Sets New 1-Year Low After Analyst Downgrade - MarketBeatMarketBeat · Tue, 11 Aug 2026 00:46:08 GMTSionna Therapeutics (NASDAQ:SION) Downgraded to "Neutral" Rating by BTIG Research - MarketBeatMarketBeat · Mon, 10 Aug 2026 20:13:38 GMTGuggenheim Reiterates Neutral Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeatMarketBeat · Mon, 10 Aug 2026 18:14:23 GMTSionna Therapeutics' (SION) "Neutral" Rating Reiterated at Wedbush - MarketBeatMarketBeat · Mon, 10 Aug 2026 16:10:28 GMTSionna Therapeutics (NASDAQ:SION) Upgraded to "Sector Perform" at Royal Bank Of Canada - MarketBeatMarketBeat · Mon, 10 Aug 2026 16:10:14 GMTSionna Therapeutics (NASDAQ:SION) Cut to "Market Perform" at Raymond James Financial - MarketBeatMarketBeat · Mon, 10 Aug 2026 16:10:02 GMTSionna Therapeutics (NASDAQ:SION) Stock Rating Lowered by Citizens Jmp - MarketBeatMarketBeat · Mon, 10 Aug 2026 16:08:47 GMT